| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $813K | +1318.8% |
| Cost of Revenue | $303K | -92.3% |
| Gross Profit | $510K | +113.2% |
| R&D Expense | $1.9M | -86.8% |
| SG&A Expense | $17.2M | +19.8% |
| Operating Income | -$46.7M | +4.1% |
| Interest Expense | $380K | — |
| Income Tax | -$31K | — |
| Net Income | -$45.3M | +9.0% |
| EPS (Basic) | -$9.40 | +84.3% |
| EPS (Diluted) | -$9.40 | +84.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.4M | +203.7% |
| Current Assets | $7.2M | +161.8% |
| Total Assets | $51.8M | +1311.3% |
| Current Liabilities | $2.7M | -83.2% |
| Total Liabilities | $10.7M | -36.1% |
| Stockholders' Equity | $41.1M | +413.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.8M | +51.0% |
| Capital Expenditures | $161K | +0.0% |
| Investing Cash Flow | -$72.0M | — |
| Financing Cash Flow | $91.0M | +418.6% |
| Free Cash Flow | -$14.9M | +50.7% |